| Bioactivity | Aladotril (BP1137) is the inhibitor for neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE), that ameliorates the cardiac hypertrophy in rats, without decreasing the blood pressure. Aladotril can be used in research about heart failure and cardiac remodeling after myocardial infarction[1]. |
| CAS | 173429-64-6 |
| Formula | C21H23NO5S |
| Molar Mass | 401.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Marie C, et al., Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction. Cardiovasc Res. 1999 Mar;41(3):544-53. |
Aladotril
CAS: 173429-64-6 F: C21H23NO5S W: 401.48
Aladotril (BP1137) is the inhibitor for neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE), that amelio
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.